NAVA Use in Preterm Neonates With Respiratory Distress Syndrome
NCT07926009, Not applicable, Recruiting, Ain Shams University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | NAVA Use in Preterm Neonates With Respiratory Distress Syndrome | ClinicalTrials.gov |
| NCT number | NCT07926009 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 30 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Ain Shams University | ClinicalTrials.gov |
| Conditions | Preterm , Respiratory Distress Syndrome, Preterm Respiratory Distress Syndrome | ClinicalTrials.gov |
| Interventions | Maquet [servo-n], Drager , SLE 5000, SLE 6000 | ClinicalTrials.gov |
| First posted | 2026-11-09 | ClinicalTrials.gov |
| Last updated | 2026-11-09 | ClinicalTrials.gov |
Registered outcomes 7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Echocardiography | baseline and after 24 hours from enrollment in the study | to assess any structural cardiac anomalies, the patency of ductus arteriosus, right ventricular output (RVO), left ventricular output (LVO), and superior vena cava (SVC) flow, ejection fraction (EF) and pulmonary pressure performed by a specialized echocardiographist. | ClinicalTrials.gov |
| Secondary | Transcranial ultrasonography Doppler | baseline and after 24 hours from enrollment in the study | applied to the middle cerebral artery to provide an estimate of cerebral blood flow performed by a specialized pediatric radiologist . | ClinicalTrials.gov |
| Secondary | Duration of admission | up to 8 weeks or till patient discharged or die which comes first | To document total number of days of admission | ClinicalTrials.gov |
| Secondary | Mortality rate | up to 8 weeks or till patient death which comes first | To document incidence of mortality during hospitalization | ClinicalTrials.gov |
| Secondary | Incidence of feeding intolerance | up to 8 weeks or till patient discharged or die which comes first | Percentage of Patients who developed feeding intolerance | ClinicalTrials.gov |
| Secondary | Days to reach full intake | up to 8 weeks or till patient discharged or die which comes first | Number of days needed by each patient to reach full intake | ClinicalTrials.gov |
| Secondary | Chest x ray change | upon NICU admission and one hour after enrollment in the study . | Chest x ray grading of RDS performed to patient before and after the assigned mode to compare lung aeration degree | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)